Lifeward (LFWD) Enterprise Value (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -425.59% |
| Dec 31, 2025 | -8.45% |
| Sep 30, 2025 | 61.08% |
| Jun 30, 2025 | 10.28% |
| Mar 31, 2025 | 15.09% |
| Dec 31, 2024 | 36.68% |
| Sep 30, 2024 | 29.59% |
| Jun 30, 2024 | 26.90% |
| Mar 31, 2024 | 26.29% |
| Dec 31, 2023 | 13.83% |
| Sep 30, 2023 | 44.00% |
| Jun 30, 2023 | 5.95% |
| Mar 31, 2023 | 8.86% |
| Dec 31, 2022 | 8.25% |
| Sep 30, 2022 | 6.09% |
| Jun 30, 2022 | 4.60% |
| Mar 31, 2022 | 6.49% |
| Dec 31, 2021 | 3.17% |
| Sep 30, 2021 | -42.02% |
| Jun 30, 2021 | 4.71% |
| Mar 31, 2021 | -231.26% |
| Dec 31, 2020 | -12.74% |
| Sep 30, 2020 | -28.34% |
| Jun 30, 2020 | 15.29% |
| Mar 31, 2020 | -2.15% |
| Dec 31, 2019 | 20.37% |
| Sep 30, 2019 | 15.15% |
| Jun 30, 2019 | -171.43% |
| Mar 31, 2019 | 7.17% |
| Dec 31, 2018 | -82.52% |
| Sep 30, 2018 | 42.49% |
| Jun 30, 2018 | -3.13% |
| Mar 31, 2018 | 39.47% |
| Dec 31, 2017 | -12.68% |
| Sep 30, 2017 | 20.47% |
| Jun 30, 2017 | 5.10% |
| Mar 31, 2017 | 27.66% |
| Dec 31, 2016 | -90.97% |
| Sep 30, 2016 | 20.95% |
| Jun 30, 2016 | 28.08% |
| Mar 31, 2016 | -22.05% |
| Dec 31, 2015 | 28.92% |
| Sep 30, 2015 | 19.36% |
| Jun 30, 2015 | 15.67% |
| Mar 31, 2015 | 15.02% |
| Dec 31, 2014 | 8.78% |
| Sep 30, 2014 | -5,174.78% |
| Dec 31, 2013 | -126.83% |